Aminocaproic acid (Amicar, Amicar Intravenous)
Aminocaproic acid
Wyeth SA (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Wyeth SA (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Amicar syrup 250 MG / ML EACH 1 ML SYRUP CONTAINS AMINOCAPROIC ACID A 250 MG | 250 MG / MLSyrup | H0685 | Cancelled | Not determined | None |
| Amicar tablets 500 MG EACH TABLET CONTAINS AMINOCAPROIC ACID A 500 mg | 500 mgTablets | H0686 | Cancelled | Not determined | None |
| Amicar intravenous infusion EACH 20 ml VIAL CONTAINS AMINOCAPROIC ACID A 5,0 g | Infusion | H0688 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.